Wolfe Research Initiates Coverage On Pharvaris with Outperform Rating, Announces Price Target of $42

Wolfe Research analyst Andy Chen initiates coverage on Pharvaris (NASDAQ:PHVS) with a Outperform rating and announces Price Target of $42.